IGF1 and amyotrophic lateral sclerosis: In ALS mice (mutant hSOD1G93A), 4 of the 50 mice (in the US or US IGF1 groups) that underwent a total of 242 BSCB opening procedures, had complications, potentially related to US treatments (1.7% of procedures, Supplementary Table S2).